» Articles » PMID: 20118915

Retroviral Intasome Assembly and Inhibition of DNA Strand Transfer

Overview
Journal Nature
Specialty Science
Date 2010 Feb 2
PMID 20118915
Citations 367
Authors
Affiliations
Soon will be listed here.
Abstract

Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.

Citing Articles

Novel Dolutegravir and Lenacapavir Resistance Patterns in Human Immunodeficiency Virus Type 2 Infection: A Case Report.

van Kampen J, van Nood E, Mahmud R, Krullaars Z, Voskamp T, Voskamp M Open Forum Infect Dis. 2025; 12(1):ofae705.

PMID: 39741997 PMC: 11685954. DOI: 10.1093/ofid/ofae705.


HIV-1 Intasomes Assembled with Excess Integrase C-Terminal Domain Protein Facilitate Structural Studies by Cryo-EM and Reveal the Role of the Integrase C-Terminal Tail in HIV-1 Integration.

Li M, Li Z, Chen X, Cui Y, Engelman A, Craigie R Viruses. 2024; 16(7).

PMID: 39066328 PMC: 11281638. DOI: 10.3390/v16071166.


Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention.

Kalemera M, Maher A, Dominguez-Villar M, Maertens G Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931397 PMC: 11206710. DOI: 10.3390/ph17060730.


Brief Histories of Retroviral Integration Research and Associated International Conferences.

Grandgenett D, Engelman A Viruses. 2024; 16(4).

PMID: 38675945 PMC: 11054761. DOI: 10.3390/v16040604.


The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject Matter.

Apetroaei M, Velescu B, Nedea M, Dinu-Pirvu C, Draganescu D, Faca A Biomedicines. 2024; 12(4).

PMID: 38672269 PMC: 11048092. DOI: 10.3390/biomedicines12040915.


References
1.
Engelman A, Hickman A, Craigie R . The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J Virol. 1994; 68(9):5911-7. PMC: 236996. DOI: 10.1128/JVI.68.9.5911-5917.1994. View

2.
Valkov E, Gupta S, Hare S, Helander A, Roversi P, McClure M . Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res. 2008; 37(1):243-55. PMC: 2615609. DOI: 10.1093/nar/gkn938. View

3.
Davies D, Goryshin I, Reznikoff W, Rayment I . Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science. 2000; 289(5476):77-85. DOI: 10.1126/science.289.5476.77. View

4.
Zwart P, Afonine P, Grosse-Kunstleve R, Hung L, Ioerger T, McCoy A . Automated structure solution with the PHENIX suite. Methods Mol Biol. 2008; 426:419-35. DOI: 10.1007/978-1-60327-058-8_28. View

5.
Chen Z, Yan Y, Munshi S, Li Y, Xu B, Witmer M . X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform. J Mol Biol. 2000; 296(2):521-33. DOI: 10.1006/jmbi.1999.3451. View